SCYNEXIS, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
SCYNEXIS, Inc. (SCYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 4.40 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-10
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was -25.81K shares, a 266.64% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 30.20K shares, a 12.77% decline year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 77.97K shares, a 971.32% increase year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 37.26K shares, a 7336.73% increase year-over-year.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 165.34K shares, a 403.69% increase from fiscal 2024.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 32.83K shares, a 81.30% decline from fiscal 2023.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 175.51K shares, a 72.40% decline from fiscal 2022.
- SCYNEXIS, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 635.82K shares, a 291.83% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | -25.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 4.40K shares 10-Q · filed 2026-08-10 | 82.37K shares derived: sum of 3 quarters · filed 2026-08-10 | 119.63K shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 30.20K shares 10-Q · filed 2026-05-11 | 108.17K shares derived: sum of 2 quarters · filed 2026-05-11 | 145.43K shares derived: sum of 3 quarters · filed 2026-05-11 | 160.92K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 77.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 115.23K shares derived: sum of 2 quarters · filed 2026-03-04 | 130.72K shares derived: sum of 3 quarters · filed 2026-03-04 | 165.34K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 37.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 52.74K shares derived: sum of 2 quarters · filed 2025-11-05 | 87.37K shares 10-Q · filed 2025-11-05 | 94.65K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 15.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 50.11K shares 10-Q · filed 2025-08-13 | 57.39K shares derived: sum of 3 quarters · filed 2025-08-13 | 57.89K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | 34.63K shares 10-Q · filed 2025-05-15 | 41.90K shares derived: sum of 2 quarters · filed 2025-05-15 | 42.41K shares derived: sum of 3 quarters · filed 2025-05-15 | 54.20K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 7.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 7.78K shares derived: sum of 2 quarters · filed 2025-03-12 | 19.57K shares derived: sum of 3 quarters · filed 2025-03-12 | 32.83K shares 10-K · filed 2025-03-12 |
| 2024-09-30 | 501.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 12.29K shares derived: sum of 2 quarters · filed 2024-11-06 | 25.55K shares 10-Q · filed 2024-11-06 | 118.16K shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 11.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 25.05K shares 10-Q · filed 2024-08-08 | 117.66K shares derived: sum of 3 quarters · filed 2024-08-08 | 127.79K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 13.25K shares 10-Q · filed 2024-05-08 | 105.87K shares derived: sum of 2 quarters · filed 2024-05-08 | 115.99K shares derived: sum of 3 quarters · filed 2024-05-08 | 154.85K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 92.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 102.74K shares derived: sum of 2 quarters · filed 2024-03-28 | 141.59K shares derived: sum of 3 quarters · filed 2024-03-28 | 175.51K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 10.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 48.98K shares derived: sum of 2 quarters · filed 2023-11-13 | 82.90K shares 10-Q · filed 2023-11-13 | 637.59K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 38.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 72.77K shares 10-Q · filed 2023-08-14 | 627.47K shares derived: sum of 3 quarters · filed 2023-08-14 | 648.47K shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 33.92K shares 10-Q · filed 2023-05-10 | 588.61K shares derived: sum of 2 quarters · filed 2023-05-10 | 609.61K shares derived: sum of 3 quarters · filed 2023-05-10 | 627.21K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 554.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 575.69K shares derived: sum of 2 quarters · filed 2023-03-31 | 593.29K shares derived: sum of 3 quarters · filed 2023-03-31 | 635.82K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 21.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 38.59K shares derived: sum of 2 quarters · filed 2022-11-09 | 81.12K shares 10-Q · filed 2022-11-09 | 217.80K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 17.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 60.12K shares 10-Q · filed 2022-08-15 | 196.80K shares derived: sum of 3 quarters · filed 2022-08-15 | 202.08K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 42.53K shares 10-Q · filed 2022-05-12 | 179.21K shares derived: sum of 2 quarters · filed 2022-05-12 | 184.49K shares derived: sum of 3 quarters · filed 2022-05-12 | 200.61K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 136.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 141.95K shares derived: sum of 2 quarters · filed 2022-03-29 | 158.08K shares derived: sum of 3 quarters · filed 2022-03-29 | 162.27K shares 10-K · filed 2022-03-29 |
| 2021-09-30 | 5.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 21.40K shares derived: sum of 2 quarters · filed 2021-11-10 | 25.59K shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 16.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 20.31K shares 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | 4.19K shares 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 45.00K shares 10-K · filed 2021-03-29 | |||
| 2019-12-31 | 470.05K shares 10-K · filed 2020-03-11 | |||
| 2018-12-31 | 282.61K shares 10-K · filed 2019-03-14 | |||
| 2017-12-31 | 220.00 shares 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |